2019.02.18 FDA 510(k) The 510(k) Program: Evaluating Substantial Equivalence in Premarket Notifications [510(k)]
FDA 2021.07.07 FDA査察の優先順位 COPY TITLE&URL https://www.youtube.com/watch?v=022lq6pmdFY ]]> Tweet Share Hatena Pocket RSS feedly Pin it What is labeling? Previous post 監査証跡の重要性 Next post
Comment